Skip to main content

Iñigo Ojanguren Arranz

Institutions of which they are part

Main researcher
Pneumology
Vall Hebron Institut de Recerca

Iñigo Ojanguren Arranz

Institutions of which they are part

Main researcher
Pneumology
Vall Hebron Institut de Recerca

Projects

Estudio de los mecanismos de progresión a fibriosis pulmonar en pacientres con neumonitis por hipersensibilidad.

IP: Mª Jesús Cruz Carmona
Collaborators: Iñigo Ojanguren Arranz
Funding agency: Instituto de Salud Carlos III
Funding: 111320
Reference: PI18/00345
Duration: 01/01/2019 - 30/06/2023

Grup de Recerca de Pneumologia

IP: Jaume Ferrer Sancho
Collaborators: Esther Rodríguez González, Sergi Martí Beltran, Mª Jose Jurado Luque, Marc Miravitlles Fernández, Ana Villar Gomez, Antonio Román Broto, Antonio Álvarez Fernandez, Victor Monforte Torres, Patricia Lloberes Canadell, Javier de Gracia Roldán, Odile Romero Santo-Tomas, Sonia Lopez Rodriguez, Montserrat Murillo Andres, Miriam Barrecheguren Fernández, Carles Bravo Masgoret, Mario Culebras Amigo, Fco. Javier Muñoz Gall, Marta Castro D la Visitación, Gabriel Sampol Rubio, Maria Antonia Ramon Belmonte, Rosa Lloria Verges, Mercedes Pallero Castillo, Mª Jesús Cruz Carmona, Cristina Berastegui Garcia, Manuel López Meseguer, Susana Gómez Olles, Berta Saez Gimenez, Iñigo Ojanguren Arranz, Eva Polverino
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 20000
Reference: 2017SGR0434
Duration: 01/01/2017 - 30/09/2021

Estudio de los mecanismos implicados en la génesis y evolución del asma (Proyecto MEGA): Creación y seguimiento a largo plazo de una cohorte de pacientes asmáticos

IP: Fco. Javier Muñoz Gall
Collaborators: Iñigo Ojanguren Arranz
Funding agency: Instituto de Salud Carlos III
Funding: 140965
Reference: PI15/01900
Duration: 01/01/2016 - 30/11/2020

Prevalencia de sensibilizacióna proteínas aviares o fúngicas en diferentes ámbitos laborales: trabajadores de empresas de control de aves y trabajadores de parques y jardines

IP: Mª Jesús Cruz Carmona
Collaborators: Ana Villar Gomez, Iñigo Ojanguren Arranz
Funding agency: Instituto de Salud Carlos III
Funding: 86515
Reference: PI15/01954
Duration: 01/01/2016 - 30/11/2020

Related news

Vall d'Hebron participated in the study in which more than half of the patients who received treatment with bacteriophages experienced significant improvements

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Pulmonary hypertension is a risk factor for patients who need surgery and, therefore, defining strategies for its management is important to allow a favorable clinical evolution.

Related professionals

Adria Aterido Ballonga

Adria Aterido Ballonga

Postdoctoral researcher
Rheumatology
Read more
Mònica Pons Delgado

Mònica Pons Delgado

Predoctoral researcher
Liver Diseases
Read more
Elena Granell  Pallares

Elena Granell Pallares

Administration and Management
Rheumatology
Read more
David Gurwitz

David Gurwitz

Senior researcher
Systemic Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.